gastric cancer, liver cancer, pancreatic cancer
Conditions
Interventions
Index test:PET/CT examination.
Sponsors
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. a. Those who are pathologically diagnosed as primary gastric adenocarcinoma and plan to perform PET/CT imaging; b. Pathologically diagnosed as a primary neuroendocrine tumor of the pancreas and proposed PET/CT imaging; c. Those who are pathologically diagnosed as primary malignant tumor of liver and plan to perform PET/CT imaging. 2. Tumor diagnostic criteria: The diagnosis and classification of liver cancer, gastric cancer and pancreatic cancer shall be carried out according to the 2019 WHO classification criteria for digestive tract tumors; 3. Do not take or inject drugs that interfere with imaging of relevant radionuclide labeled probe within 3 days before PET/CT examination; 4. Obtain/sign the informed consent form; 5. Did not participate in other clinical trials.
Exclusion criteria
Exclusion criteria: 1. Complicated with serious systemic diseases, such as systemic infection, cardiac insufficiency, liver and kidney insufficiency, blood disease, thyroid disease, autoimmune disease, etc; 2. Patients with tumors other than liver cancer, gastric cancer or pancreatic cancer; 3. Mental disorders or failure to cooperate due to poor compliance of mental retardation; 4. Pregnant and lactating women; 5. Have a history of surgery and trauma that significantly affect the metabolic distribution and anatomical structure; 6. Other situations judged by the researcher to be unsuitable for this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum standard uptake value; | — |
Countries
China
Contacts
Public ContactCheng Dengfeng
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University
Outcome results
None listed